US SB113 | 2023-2024 | 118th Congress
Status
Spectrum: Bipartisan Bill
Status: Introduced on January 26 2023 - 25% progression
Action: 2023-03-01 - Placed on Senate Legislative Calendar under General Orders. Calendar No. 19.
Text: Latest bill text (Introduced) [PDF]
Status: Introduced on January 26 2023 - 25% progression
Action: 2023-03-01 - Placed on Senate Legislative Calendar under General Orders. Calendar No. 19.
Text: Latest bill text (Introduced) [PDF]
Summary
A bill to require the Federal Trade Commission to study the role of intermediaries in the pharmaceutical supply chain and provide Congress with appropriate policy recommendations, and for other purposes.
Title
Prescription Pricing for the People Act of 2023
Sponsors
| Sen. Chuck Grassley [R-IA] | Sen. Maria Cantwell [D-WA] | Sen. Richard Blumenthal [D-CT] | Sen. James Lankford [R-OK] |
| Sen. Marsha Blackburn [R-TN] | Sen. Tommy Tuberville [R-AL] | Sen. Thom Tillis [R-NC] | Sen. Shelley Capito [R-WV] |
| Sen. Mike Braun [R-IN] | Sen. John Boozman [R-AR] | Sen. Peter Welch [D-VT] | Sen. Christopher Coons [D-DE] |
| Sen. Mazie Hirono [D-HI] | Sen. Dianne Feinstein [D-CA] | Sen. Robert Casey [D-PA] | Sen. Kyrsten Sinema [I-AZ] |
| Sen. Roger Marshall [R-KS] | Sen. Ted Budd [R-NC] | Sen. Jacky Rosen [D-NV] | Sen. Jeanne Shaheen [D-NH] |
| Sen. Susan Collins [R-ME] |
History
| Date | Chamber | Action |
|---|---|---|
| 2023-03-01 | Senate | Placed on Senate Legislative Calendar under General Orders. Calendar No. 19. |
| 2023-03-01 | Senate | Committee on the Judiciary. Reported by Senator Durbin with an amendment in the nature of a substitute. Without written report. |
| 2023-02-09 | Senate | Committee on the Judiciary. Ordered to be reported with an amendment in the nature of a substitute favorably. |
| 2023-01-26 | Senate | Read twice and referred to the Committee on the Judiciary. |
